{"pub": "marketwatch", "url": "https://marketwatch.com/articles/ovid-therapeutics-sunrun-pure-cycle-and-other-13d-filings-51570839824", "downloaded_at": "2019-10-12 01:00:42.844132+00:00", "title": "Ovid Therapeutics, Sunrun, Pure Cycle, and Other 13D Filings", "language": "en", "text": "13Ds are filed with the Securities and Exchange Commission within 10 days of an entity\u2019s attaining a greater than 5% position in any class of a company\u2019s securities. Subsequent changes in holdings or intentions must be reported in amended filings. This material has been extracted from filings released by the SEC from Oct. 3, 2019, to Oct. 9, 2019. Source: InsiderScore.com\n\nActivist Holdings Ovid Therapeutics (OVID)\n\nTLS Advisors disclosed on Oct. 7 that it held 3,466,394 shares of the small-cap biopharmaceutical company after...", "description": "SEC filings on Ovid Therapeutics, Sunrun, Pure Cycle, and seven other companies", "authors": [], "top_image": "https://asset.barrons.com/public/resources/images/ON-DE479_Barron_OR_20190823133304.jpg", "published_at": "2019-10-11"}